Weiwei Yan
Department Of Shandong Provincial Key Laboratory Of Precision Oncology
Jinan, China
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Treatment-Related Cardiotoxicity in Non-Small Cell Lung Cancer: A Population-Based Analysis for Risk Stratification.
Journal: QJM : monthly journal of the Association of Physicians
Published: October 27, 2025
Neutrophil extracellular traps predict poor response and prognosis in non-small cell lung cancer immunotherapy.
Journal: Therapeutic advances in medical oncology
Published: June 03, 2025
CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profiling.
Journal: Therapeutic advances in medical oncology
Published: May 15, 2024
Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer.
Journal: Journal of inflammation research
Published: May 07, 2024
Potential Role of Lymphocyte CD44 in Determining Treatment Selection Between Stereotactic Body Radiation Therapy and Surgery for Early-Stage Non-Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: July 20, 2023
Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC.
Journal: Cancer medicine
Published: May 21, 2020
Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
Journal: OncoTargets and therapy
Published: September 10, 2019
Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report.
Journal: OncoTargets and therapy
Published: July 02, 2019
Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis.
Journal: Radiation oncology (London, England)
Published: June 29, 2019
Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
Journal: Cancer biology & therapy
Published: April 16, 2019
Last Updated: 09/26/2026